HelaPlex, a commercial shared office and lab space, chose Scispot™ as their exclusive digital platform to create the world’s first digital life science accelerator. As part of this partnership, HelaPlex will gain access to a white label digital operating platform powered by Scispot™.
HelaPlex will allocate a secure digital space to each of its members that will enable them to manage their research, resources, and partners in one spot per commercial regulatory requirements.
“I believe the bio revolution is on the horizon and it will be led by virtual and semi-virtual life science companies,” said Guru Singh, CEO of Scispot.io.
“Digitally powering HelaPlex companies early on will give these startups an upper hand over their competitors and bigger counterparts. This partnership sets the foundation for the virtualization and democratization of this industry.”
“Together, Scispot™ and HelaPlex strive to accelerate the commercial development of life science assets by startup communities in Philadelphia while simultaneously de-risking investment for their respective financiers, i.e. angel investors, venture capitalists, and private equity investors,” stated Tia Lyles-Williams, CEO of HelaPlex.
“This partnership underscores HelaPlex’s commitment to empowering bioentrepreneurs. HelaPlex will enable the most talented and ambitious bioentrepreneurs in accelerating their assets to become the next multi-billion-dollar companies.”
Scispot™ has joined forces with numerous other incubators, accelerators, and shared lab spaces including IndieBio, a leading biotech accelerator. With these partnerships, Scispot™ aims to create a community of thousands of smart digital biotech™ working in an interconnected collaborative network to help solve humanity's biggest problems.
Visit the company LinkedIn page, or request a demo to join the biotech revolution.